These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 7563673)
1. [Viral escape from humoral immune system by mutations in hypervariable region of HCV envelope protein and mechanism of persistent viral infection]. Kato N; Nakazawa T; Sekiya H; Mizutani T; Shimotohno K Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):129-35. PubMed ID: 7563673 [No Abstract] [Full Text] [Related]
2. Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus. Christie JM; Chapel H; Chapman RW; Rosenberg WM Hepatology; 1999 Oct; 30(4):1037-44. PubMed ID: 10498657 [TBL] [Abstract][Full Text] [Related]
3. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library. Mink MA; Benichou S; Madaule P; Tiollais P; Prince AM; Inchauspe G Virology; 1994 Apr; 200(1):246-55. PubMed ID: 7510436 [TBL] [Abstract][Full Text] [Related]
4. [Sequence diversity and variability in the putative envelope proteins including hypervariable regions of hepatitis C virus]. Nakazawa T; Hijikata M; Kato N; Shimotohno K Nihon Rinsho; 1993 Feb; 51(2):318-22. PubMed ID: 8385235 [TBL] [Abstract][Full Text] [Related]
5. Predominance of antibodies to hepatitis C virus envelope proteins in various disease statuses of hepatitis C. PodurI CD; Khanna A; Khundmiri SJ; Khaja MN; Kumar KS; Sugunan VS; Habibullah CM; Das MR Acta Virol; 2001 Feb; 45(1):1-6. PubMed ID: 11394572 [TBL] [Abstract][Full Text] [Related]
6. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Zibert A; Schreier E; Roggendorf M Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251 [TBL] [Abstract][Full Text] [Related]
7. [Mechanism of persistent infection of hepatitis C virus in humoral immune system]. Hiramoto J; Hirakawa G; Nagayama K Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):151-4. PubMed ID: 15359783 [No Abstract] [Full Text] [Related]
8. Evolutionary study of hepatitis C virus envelope genes during primary infection. Chen S; Wang YM Chin Med J (Engl); 2007 Dec; 120(24):2174-80. PubMed ID: 18167197 [TBL] [Abstract][Full Text] [Related]
9. [Cloning and sequencing of cDNA of E2/NS1 gene of hepatitis C virus]. Shen D; Lu H; Li M; He L; Shang D; Ma X Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):227-31. PubMed ID: 15617335 [TBL] [Abstract][Full Text] [Related]
10. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice. Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486 [TBL] [Abstract][Full Text] [Related]
11. [An analysis of the B-cell epitopes recognized in hypervariable region 1 of hepatitis C virus in chronic persistent hepatitis]. Nakamoto Y; Murakami S Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):117-22. PubMed ID: 7563669 [No Abstract] [Full Text] [Related]
12. In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Bartosch B; Bukh J; Meunier JC; Granier C; Engle RE; Blackwelder WC; Emerson SU; Cosset FL; Purcell RH Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14199-204. PubMed ID: 14617769 [TBL] [Abstract][Full Text] [Related]
13. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants. Puntoriero G; Meola A; Lahm A; Zucchelli S; Ercole BB; Tafi R; Pezzanera M; Mondelli MU; Cortese R; Tramontano A; Galfre' G; Nicosia A EMBO J; 1998 Jul; 17(13):3521-33. PubMed ID: 9649423 [TBL] [Abstract][Full Text] [Related]
14. Characterization of hypervariable region in hepatitis C virus envelope protein during acute and chronic infection. Higashi K; Tsukiyama-Kohara K; Tanaka T; Tanaka E; Kiyosawa K; Kohara M Arch Virol; 2005 May; 150(5):883-98. PubMed ID: 15662481 [TBL] [Abstract][Full Text] [Related]
15. Association of hepatitis C virus particles with immunoglobulin: a mechanism for persistent infection. Choo SH; So HS; Cho JM; Ryu WS J Gen Virol; 1995 Sep; 76 ( Pt 9)():2337-41. PubMed ID: 7561774 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Booth JC; Kumar U; Webster D; Monjardino J; Thomas HC Hepatology; 1998 Jan; 27(1):223-7. PubMed ID: 9425941 [TBL] [Abstract][Full Text] [Related]
17. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome. Aiyama T; Yoshioka K; Okumura A; Takayanagi M; Iwata K; Ishikawa T; Kakumu S Hepatology; 1996 Dec; 24(6):1346-50. PubMed ID: 8938159 [TBL] [Abstract][Full Text] [Related]
18. Broadly reactive antibodies to hypervariable region 1 in hepatitis C virus-infected patient sera: relation to viral loads and response to interferon. Hattori M; Yoshioka K; Aiyama T; Iwata K; Terazawa Y; Ishigami M; Yano M; Kakumu S Hepatology; 1998 Jun; 27(6):1703-10. PubMed ID: 9620346 [TBL] [Abstract][Full Text] [Related]
19. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease. Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394 [TBL] [Abstract][Full Text] [Related]
20. Variant analysis and immunogenicity prediction of envelope gene of HCV strains from China. Cai Q; Zhang X; Tian L; Yuan M; Jin G; Lu Z J Med Virol; 2002 Aug; 67(4):490-500. PubMed ID: 12115994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]